T1 mapping in ischaemic heart disease

European Heart Journal Cardiovascular Imaging

Volumn 15, Issue 6, 2014, Pages 597-602

  O H Ici, Darach ^a,b   Jeuthe, Sarah ^a   Al Wakeel, Nadya ^a   Berger, Felix ^a   Kuehne, Titus ^a   Kozerke, Sebastian ^b,c   Messroghli, Daniel R ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c ETH ZURICH   (Switzerland)

Author keywords

ECV; Ischaemic heart disease; Myocardial infarction; Myocardial ischaemia; T1 Mapping

Indexed keywords

ACUTE HEART INFARCTION; CARDIOVASCULAR MAGNETIC RESONANCE; DIAGNOSTIC VALUE; EXTRACELLULAR SPACE; HEART EDEMA; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REPRODUCIBILITY; REVIEW; DIAGNOSTIC USE; FEMALE; IMAGE PROCESSING; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; SENSITIVITY AND SPECIFICITY;

GADOLINIUM PENTETATE;

FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; SENSITIVITY AND SPECIFICITY;

EID: 84901264445     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jeu024     Document Type: Review

References (54)

1. Akber SF.Water proton relaxation times of pathological tissues. Physiol Chem Phys Med NMR 2008;40: 1-42.
2. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004;52: 141-6.
3. Piechnik SK, Ferreira VM, Dall'Armellina E, Cochlin LE, Greiser A, Neubauer S et al. Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson 2010;12: 69.
4. Damadian R. Tumor detection by nuclear magnetic resonance. Science 1971;171: 1151-3.
5. Williams ES, Kaplan JI, Thatcher F, Zimmerman G, Knoebel SB. Prolongation of proton spin lattice relaxation times in regionally ischemic tissue from dog hearts. J Nucl Med 1980;21: 449-53.
6. Been M, Smith MA, Ridgeway JP, Brydon JW, Douglas RH, KeanDMet al. Characterisation of acute myocardial infarction by gated magnetic resonance imaging. Lancet 1985;2: 348-50.
7. Wisenberg G, Prato FS, Carroll SE, Turner KL, Marshall T. Serial nuclear magnetic resonance imaging of acute myocardial infarction with and without reperfusion. Am Heart J 1988;115: 510-8.
8. Been M, SmithMA, Ridgway JP, Douglas RH, de BonoDP, Best JJ et al. Serial changes in the T1 magnetic relaxation parameter after myocardial infarction in man. Br Heart J 1988;59: 1-8.
9. Abdel-Aty H, Boye P, Zagrosek A,Wassmuth R, Kumar A, Messroghli D et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: Comparison of different approaches. J Am Coll Cardiol 2005;45: 1815-22.
10. Oh-Ici D, Ridgway JP, KuehneT, Berger F, Plein S, SivananthanMet al. Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: Diagnostic accuracy of visual and semiquantitative assessment. J Cardiovasc Magn Reson 2012;14: 22.
11. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146: 3-15.
12. Vinnakota KC, Bassingthwaighte JB. Myocardial density and composition: A basis for calculating intracellular metabolite concentrations. Am J Physiol Heart Circ Physiol 2004;286: H1742-9.
13. Jennings RB, Ganote CE, Reimer KA. Ischemic tissue injury. Am J Pathol 1975;81: 179-98.
14. Powell WJ Jr, DiBona DR, Flores J, Leaf A. The protective effect of hyperosmotic mannitol in myocardial ischemia and necrosis. Circulation 1976;54: 603-15.
15. Jennings RB, Schaper J, Hill ML, Steenbergen C Jr, Reimer KA. Effect of reperfusion late in the phase of reversible ischemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 1985;56: 262-78.
16. Reimer KA, Jennings RB, Hill ML. Total ischemia in dog hearts, in vitro High energy phosphate depletion and associated defects in energy metabolism, cell volume regulation, and sarcolemmal integrity. Circ Res 1981;49: 901-11.
17. Buja LM. Myocardial ischemia and reperfusion injury. Cardiovasc Pathol 2005;14: 170-5.
18. Garcia-Dorado D, Oliveras J. Myocardial oedema: A preventable cause of reperfusion injury? Cardiovasc Res 1993;27: 1555-63.
19. Tranum-Jensen J, Janse MJ, Fiolet WT, Krieger WJ, D'Alnoncourt CN, Durrer D. Tissue osmolality, cell swelling, and reperfusion in acute regional myocardial ischemia in the isolated porcine heart. Circ Res 1981;49: 364-81.
20. Messroghli DR,Walters K, Plein S, Sparrow P, Friedrich MG, Ridgway JP et al. Myocardial T1 mapping: Application to patients with acute and chronic myocardial infarction. Magn Reson Med 2007;58: 34-40.
21. Dall'Armellina E, Piechnik SK, Ferreira VM, Si QL, Robson MD, Francis JM et al. Cardiovascular magnetic resonance by non contrast T1-mapping allows assessment of severity of injury in acute myocardial infarction. J Cardiovasc Magn Reson 2012;14: 15.
22. Goldfarb JW, Arnold S, Han J. Recent myocardial infarction: Assessment with unenhanced T1-weighted MR imaging. Radiology 2007;245: 245-50.
23. Yan AT, Shayne AJ, Brown KA, Gupta SN, ChanCW, Luu TM et al. Characterization of the peri-infarct zone by contrast-enhanced cardiac magnetic resonance imaging is a powerful predictor of post-myocardial infarction mortality. Circulation 2006;114: 32-9.
24. Ugander M, Zemedkun M, Hsu L-Y, Oki AJ, Booker OJ, Kellman P et al. Non-contrast quantitative T1-mapping indicates that salvaged myocardium developsedema during coronary occlusion, whereas infarction exhibits evidence of additional reperfusion injury. J Cardiovasc Magn Reson 2011;13(Suppl. 1): O63.
25. Higgins CB, Herfkens R, Lipton MJ, Sievers R, Sheldon P, Kaufman L et al. Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: Alterations in magnetic relaxation times. Am J Cardiol 1983;52: 184-8.
26. McNamara MT, Higgins CB, Schechtmann N, Botvinick E, Lipton MJ, Chatterjee K et al. Detection and characterization of acute myocardial infarction in man with use of gated magnetic resonance. Circulation 1985;71: 717-24.
27. Friedrich MG, KimHW, Kim RJ. T2-weighted imaging to assess post-infarct myocardium at risk. JACC Cardiovasc Imaging 2011;4: 1014-21.
28. Giri S, Chung YC, Merchant A, Mihai G, Rajagopalan S, Raman SV et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 2009; 11: 56.
29. Rapoport S, Sostman HD, Pope C, Camputaro CM, HolcombW, Gore JC. Venous clots: Evaluation with MR imaging. Radiology 1987;162: 527-30.
30. Pedersen SF, Thrysoe SA, Robich MP, Paaske WP, Ringgaard S, Botker HE et al. Assessment of intramyocardial hemorrhage by T1-weighted cardiovascular magnetic resonance in reperfused acute myocardial infarction. J Cardiovasc Magn Reson 2012;14: 59.
31. Fishbein MC, Maclean D, Maroko PR. The histopathologic evolution of myocardial infarction. Chest 1978;73: 843-9.
32. Nucifora G, Aquaro GD, Masci PG, Barison A, Todiere G, Pingitore A et al. Lipomatous metaplasia in ischemic cardiomyopathy: Current knowledge and clinical perspective. Int J Cardiol 2011;146: 120-2.
33. Ferreira VM, Holloway CJ, Piechnik SK, Karamitsos TD, Neubauer S. Is it really fat? Ask a T1-map. Eur Heart J Cardiovasc Imaging 2013;14: 1060.
34. Kloner RA, Jennings RB. Consequences of brief ischemia: Stunning, preconditioning, and their clinical implications: Part. Circulation 2001;104: 3158-67.
35. Aletras AH, Tilak GS, Natanzon A,Hsu LY, Gonzalez FM, HoytRF Jr et al. Retrospective determination of the area at risk for reperfused acute myocardial infarction with T2-weighted cardiac magnetic resonance imaging: Histopathological and displacement encoding with stimulated echoes (DENSE) functional validations. Circulation 2006;113: 1865-70.
36. Buda AJ, Aisen AM, Juni JE, Gallagher KP, Zotz RJ. Detection and sizing of myocardial ischemia and infarction by nuclear magnetic resonance imaging in the canine heart. Am Heart J 1985;110: 1284-90.
37. Ugander M, Bagi PS, Oki AJ, Chen B, Hsu LY, Aletras AH et al. Myocardial edema as detected by pre-contrast T1 and T2 CMR delineates area at risk associated with acute myocardial infarction. JACC Cardiovasc Imaging 2012;5: 596-603.
38. Wong TC, Piehler K, Meier CG, Testa SM, Klock AM, Aneizi AA et al. Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality. Circulation 2012;126: 1206-16.
39. Flett AS, Hayward MP, Ashworth MT, Hansen MS, Taylor AM, Elliott PM et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans. Circulation 2010;122: 138-44.
40. Sado DM, Flett AS, Banypersad SM, White SK, Maestrini V, Quarta G et al. Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart 2012;98: 1436-41.
41. Ugander M, Oki AJ, Hsu LY, Kellman P, Greiser A, Aletras AH et al. Extracellular volume imaging by magnetic resonance imaging provides insights into overt and subclinical myocardial pathology. Eur Heart J 2012;33: 1268-78.
42. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E et al. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994; 89: 151-63.
43. UganderM, Bagi PS, Booker JO, Hsu L-y, Oki AJ, Greiser A et al. Understanding why edema in salvaged myocardium is difficult to detect by late gadolinium enhancement. J Cardiovasc Magn Reson 2012;14(Suppl. 1): O63.
44. Look DC, Locker DR. Time saving in measurement of NMR and EPR relaxation times. Rev Sci Instrum 1970;41: 250-1.
45. Chow K, Flewitt JA, Green JD, Pagano JJ, Friedrich MG, Thompson RB. Saturation recovery single-shot acquisition (SASHA) for myocardial T1 mapping. Magn Reson Med 2013; doi: 10.1002/mrm.24878. [Epub ahead of print].
46. Moon JC, Messroghli D, Kellman P, Piechnik SK, Robson MD, UganderMet al. Myocardial T1 mapping and extracellular volume quantification: A Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013;15: 92.
47. Kawel N, Nacif M, Zavodni A, Jones J, Liu S, Sibley CT et al. T1 mapping of the myocardium: Intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region. J Cardiovasc Magn Reson 2012;14: 27.
48. Messroghli DR, Plein S, Higgins DM,Walters K, Jones TR, Ridgway JP et al. Human myocardium: Single-breath-holdMRT1 mapping with high spatial resolution-reproducibility study. Radiology 2006;238: 1004-12.
49. Ferreira V, Piechnik S, Dall'Armellina E, Karamitsos T, Francis J, Friedrich M et al. Quantification of acute myocardial injury by ShMOLLI T1-Mapping, T2-weighted and late gadolinium imaging in patients presenting with chest pain, positive troponins and non-obstructive coronary arteries. J Cardiovasc Magn Reson 2011;13(Suppl. 1): P16.
50. Moreo A, Ambrosio G, De Chiara B, Pu M, Tran T, Mauri F et al. Influence of myocardial fibrosis on left ventricular diastolic function: Noninvasive assessment by cardiac magnetic resonance and echo. Circ Cardiovasc Imaging 2009;2: 437-43.
51. Oakes RS, Badger TJ, Kholmovski EG, Akoum N, Burgon NS, FishENet al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009;119: 1758-67.
52. Liu S, Han J, Nacif MS, Jones J, Kawel N, Kellman P et al. Diffuse myocardial fibrosis evaluation using cardiac magnetic resonanceT1mapping: Sample size considerations for clinical trials. J Cardiovasc Magn Reson 2012;14: 90.
53. Suranyi P, Kiss P, Brott BC, Simor T, Elgavish A, Ruzsics B et al. Percent infarct mapping: An R1-map-based CE-MRI method for determining myocardial viability distribution. Magn Reson Med 2006;56: 535-45.
54. Saeed M, HettsSW,Do L, WilsonMW. Coronary microemboli effects in preexisting acute infarcts in a swine model: Cardiac MR imaging indices, injury biomarkers, and histopathologic assessment. Radiology 2013;268: 98-108.